Clinical Trial Update: High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose isoniazid in adults with INH-resistant tuberculosis across different genetic variants; study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2023-02-17